Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function
Yunali Ashar1, Qiuxu Teng1, John N D Wurpel1
1Department of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.
Biomolecules
|August 26, 2022
Summary
Palmitic acid impairs placental development by increasing folate removal from EVTs via MRP1. N-acetylcysteine (NAC) and ABCC1 knockout reversed these effects, suggesting a link between maternal diet and fetal environment.
Area of Science:
- Reproductive biology
- Cell biology
- Biochemistry
Background:
- Placental extravillous trophoblasts (EVTs) are crucial for fetal development, mediating uteroplacental vascular remodeling.
- Adequate folate levels are essential for EVT proliferation and invasion, impacting fetal oxygen and nutrient supply.
- Multidrug resistance-associated protein 1 (MRP1) is an efflux transporter that removes folate from EVTs.
Purpose of the Study:
- To investigate the hypothesis that palmitic acid enhances MRP1-mediated folate removal from EVTs, thus disrupting placental vascular remodeling.
- To elucidate the role of palmitic acid and MRP1 in regulating EVT function.
Main Methods:
- Human first-trimester EVT cell lines (HTR-8/SVneo and Swan-71) were treated with palmitic acid.
- Gene and protein expression of MRP1 (ABCC1) were analyzed.
- Folate efflux, cell migration, and invasion assays were performed.
- Experiments included treatment with N-acetylcysteine (NAC) and use of an ABCC1 knockout cell line.
Main Results:
- Palmitic acid significantly increased ABCC1 gene and MRP1 protein expression in EVTs.
- Increased folate efflux correlated with decreased EVT migration and invasion.
- NAC treatment reversed palmitic acid-induced MRP1 upregulation and restored EVT function.
- ABCC1 knockout cells exhibited enhanced migration and invasion.
Conclusions:
- Palmitic acid promotes MRP1-mediated folate efflux from EVTs, impairing their vascular remodeling function.
- This mechanism provides a link between maternal saturated fatty acid intake and compromised fetal development.
- Targeting MRP1 or using antioxidants like NAC may offer therapeutic potential for mitigating adverse effects.


